Monogenic determinants of familial Alzheimer's disease: Presenilin-1 mutations

Cellular and Molecular Life Sciences

Volumn 54, Issue 9, 1998, Pages 902-909

  Kovacs, D M ^a   Tanzi, R E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

amyloid; Alzheimer's disease; FAD; Mutations; Neurodegeneration; Presenilin 1; PS1

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; BRAIN; CELL LINE; FAMILIAL DISEASE; GENE MUTATION; HUMAN; NERVE DEGENERATION; TRANSGENIC MOUSE;

AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEINS E; CAENORHABDITIS ELEGANS PROTEINS; CELL LINE; GENE EXPRESSION; HELMINTH PROTEINS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; NERVE DEGENERATION; PEPTIDE FRAGMENTS; PHENOTYPE; PRESENILIN-1; TRANSFECTION;

EID: 0031714867     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050219     Document Type: Article

References (86)

1. Tanzi R., Gaston S., Bush A., Romano D., Pettingell W., Peppercorn J. et al. (1994) Genetic heterogenity of gene defects responsible for familial Alzheimer disease. Genetica 91: 255-263
2. Wasco W. and Tanzi R. E. (1995) Molecular genetics of amyloid and apolipoprotein E in Alzheimer's disease. In: Neurobiology of Alzheimer's Disease, pp. 51-76, Dawbarn D. and Allen S. J. (eds), BIOS Scientific Publishers, Oxford
3. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H. et al. (1993) Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
4. Tanzi R. E., Vaula G., Romano D. M., Mortilla M., Huang T. L., Tupler R. G. et al. (1992) Assessment of amyloid β protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am. J. Hum. Genet. 51: 273-282
5. Tanzi R. E., Kovacs D. M., Kim T. W., Moir R. D., Guenette S. Y. and Wasco W. (1996) The gene defects responsible for familial Alzheimer's disease. Neurobiol. Dis. 3: 159-168
6. Rossor M. N., Fox N. C., Beck J., Campbell T. C. and Collinge J. (1996) Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. Lancet 347: 1560
7. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C. et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373: 523-527
8. Cai X.-D., Golde T. E. and Younkin S. G. (1993). Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259: 514-516
9. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L. Jr., Eckman C. et al. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264: 1336-1340
10. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P. et al. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360: 672-674
11. Hymun B. T., West H. L., Rebeck G. W., Buldyrev S. V., Mantegna R. N., Ukleja M. et al. (1995) Quantitative analysis of senile plaques in Alzheimer's disease: observation of log-normal size distribution and molecular epidemiology of differences associated with ApoE genotype and trisomy 21 (Down syndrome). Proc. Natl. Acad. Sci. USA 92: 3586-3590
12. Bales K. R., Verina T., Dodel R. C., Du Y., Altstiel L., Bender M. et al. (1997) Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Genet. 17: 263-264
13. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M. et al. (1995) Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer disease. Nature 375: 754-760
14. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H. et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977
15. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y. et al. (1995) Familial Alzheimer's disease in kindreds with missense mutation in a gene on chomosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778
16. Hong C. S. and Koo E. H. (1997) Isolation and characterization of Drosophila presenilin homolog. Neuroreport 8: 665-668
17. Boulianne G. L., Livne-Bar I., Humphreys J. M., Liang Y., Lin C., Rogaev E. et al. (1997) Cloning and characterization of the Drosophila presenilin homologue. Neuroreport 8: 1025-1029
18. Levitan D. and Greenwald I. (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377: 351-354
19. Xiajun L. and Greewald I. (1997) HOP-1, Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc. Natl. Acad. Sci. USA 94: 12204-12209
20. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20: 154-159
21. Perez-Tur J., Froelich S., Prihar G., Crook R., Baker M., Duff K. et al. (1996) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7: 297-301
22. Clark R. F. and the Alzheimer's Disease Collaboration Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet. 11: 219-222
23. Suzuki T., Nishiyama K., Murayama S., Yamamoto A., Sato S., Kanazawa I. et al. (1996) Regional and cellular presenilin 1 gene expression in human and rat tissues. Biochem. Biophys. Res. Commun. 219: 708-713
24. Kovacs D. M., Fausett H. J., Page K. J., Kim T.-W., Moir R. D., Merriam D. E. et al. (1996) Alzheimer associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2: 224-229
25. Cribbs D. H., Chen L. S., Bende S. M. and LaFerla F. M. (1996) Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain. Am. J. Pathol. 148: 1797-1806
26. Lee M. K., Slunt H. H., Martin L. J., Thinakaran G., Kim G., Gandy S. E. et al. (1996) Expression of Presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16: 7513-7525
27. Levey A. I., Heilman C. J., Lah J. J., Nash N. R., Rees H. D., Wakai M. et al. (1997) Presenilin-1 protein expression in familial and sporadic Alzheimer's disease. Ann. Neurol. 41: 742-753
28. Busciglio J., Hartmann H., Lorenzo A., Wong C., Baumann K., Sommer B. et al. (1997) Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J. Neurosci. 17: 5101-5107
29. Lah J. J., Heilman C. J., Nash N. R., Rees H. D., Yi H., Counts S. E. et al. (1997) Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci. 17: 1971-1980
30. Moussaoui S., Czech C., Pradier L., Blanchard V., Bonici B., Gohin M. et al. (1996) Immunohistochemical analysis of presenilin-1 expression in mouse brain. FEBS Lett. 383: 219-222
31. Page K., Hollister R., Tanzi R. E. and Hyman B. T. (1996) In situ hybridisation of presenilin 1 mRNA in Alzheimer's disease and in lesioned rat brain. Proc. Natl. Acad. Sci. USA 93: 14020-14024
32. Walter J., Capell A., Grünberg J., Pesold B., Schindzielorz A., Prior R. et al. (1996) The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2: 673-691
33. Cook D. G., Sung J. C., Golde T. E., Felsenstein K. M., Wojczyk B. S., Tanzi R. E. et al. (1996) Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA 93: 9223-9228
34. Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B. et al. (1997) Phosphorylalion, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272: 3590-3598
35. Dewji N. N. and Singer S. J. (1997) Cell surface expression of the Alzheimer disease-related presenilin proteins. Proc. Natl. Acad. Sci. USA 94: 9926-9931
36. Li J., Xu M., Zhou H., Ma J. and Potter H. (1997) Alzheimer presenilins in the nuclear membrane, interphase kinetochores and centrosomes suggest a role in chromosome segregation. Cell 90: 917-927
37. Seeger M., Nordstedt C., Petanceska S., Kovacs D. M., Gouras G. K., Hahne S. et al. (1997) Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc. Natl. Acad. Sci. USA 94: 5090-5094
38. Walter J., Grünberg J., Capell A., Pesold B., Schindzielorz A., Citron M. et al. (1997) Proteolytic processing of the Alzheimer disease-associated presenilin-1 gene generates an in vivo substrate for protein kinase C. Proc. Natl. Acad. Sci. USA 94: 5349-5354
39. Doan A., Thinakaran G., Borchelt D. R., Slunt H. H., Ratovitsky T., Podlisny M. et al. (1996) Protein topology of presenilin 1. Neuron 17: 1023-1030
40. Lehmann S., Chiesa R. and Harris D. A. (1997) Evidence for a six-transmembrane domain structure of presenilin 1. J. Biol. Chem. 272: 12047-12051
41. Kim T.-W., Hallmark O. G., Pettingell W., Wasco W. and Tanzi R. E. (1996) Proteolytic processing of wild-type and mutant forms of presenilin 2. Neurobiol. Aging 17: S155
42. Thinakaran G., Borchelt D., Lee M., Slunt H., Spitzer L., Kim G. et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17: 181-190
43. Mercken M., Takahashi H., Honda T., Sato K., Murayama M., Nakazato Y. et al. (1996) Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett. 389: 297-303
44. Ratovitski T., Slunt H. H., Thinakaran G., Price D. L., Sisodia S. S. and Borchelt D. R. (1997) Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J. Biol. Chem. 272: 24536-24541
45. Kim T.-W., Pettingell W. H., Hallmark O. G., Moir R. D., Wasco W. and Tanzi R. E. (1997) Endoproteolytic processing and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272: 11006-11010(a)
46. Thinakaran G., Harris C. L., Ratovitsky T., Davenport F., Slunt H., Price D. L. et al. (1997) Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272: 28415-28422
47. Lee M. K., Borchelt D. R., Kim G., Thinakaran G., Slunt H. H., Ratovitski T. R. et al. (1997) Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nature Med. 3: 723-725
48. Podlisny M. B., Citron M., Amarante P., Sherrington R., Xia W., Zhang J. et al. (1997) Presenilin proteins undergo heterogenous endoproteolysis between Thr291 and Ala299 and occur as Stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol. Dis. 3: 325-337
49. Kim T.-W., Pettingell W. H., Jung Y.-K., Kovacs D. M. and Tanzi R. E. (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by caspase-3 family protease. Science 277: 373-376
50. Loetscher H., Deuschle U., Brockhaus M., Reinhardt D., Nelboeck P., Mous J. et al. (1997) Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272: 20655-20659
51. Hartmann H., Busciglio J., Baumann K.-H., Staufenbiel M. and Yankner B. A. (1997) Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation. J. Biol. Chem. 272: 14505-14508
52. Capell A., Saffrick R., Olivo J.-C., Meyn L., Walter J., Grünberg J. et al., (1997) Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation. J. Neurochem. 69: 2432-2440
53. Vito P., Ghayurt T. and D'Adamio L. (1997) Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis and caspase-3 cleavage. J. Biol. Chem. 272: 28315-28320
54. Guo Q., Furukawa K., Sopher B. L., Pham D. G., Xie J., Robinson N. et al. (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. Neuroreport 8: 379-383
55. Wolozin B., Iwasaki K., Vito P., Ganjei K., Lacana E., Sunderland T. et al. (1996) PS2 participates in cellular apoptosis: constitutive activity conferred by Alzheimer mutation. Science 274: 1710-1713
56. Denp G., Pike C. J. and Cotman C. W. (1996) Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett. 397: 50-54
57. Janicki S. and Monteiro M. J. (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N1411). J. Cell Biol. 139: 485-495
58. 2+-binding protein ALG-2 and Alzheimer's Disease Gene ALG-3. Science 271: 521-525
59. Johnson E. M. (1994) Possible role of neuronal apoptosis in Alzheimer's disease. Neurobiol. Aging 15: 5187-5189
60. Cotman C. W. and Anderson A. J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10: 19-45
61. LeBlanc A. (1996) Apoptosis and Alzheimer's disease. In: Molecular Mechanisms of Dementia, pp. 57-71, Wasco W. and Tanzi R. E. (eds), Humana Press, Totowa, NJ
62. Mellman I., Matter K., Yamamoto E., Pollack N., Roome J., Felsenstein K. et al. (1995) Mechanisms of molecular sorting in polarized cells: relevance to Alzheimer's disease. In: Alzheimer's Disease: Lessons from Cell Biology, pp. 14-26, Kosik K. S., Christen V. and Selkoe D. J. (eds), Springer, Berlin
63. Selkoe D. J. (1995) Physiological roduction and polarized secretion of the amyloid β-peptide in epithelial cells: a route to the mechanism of Alzheimer's disease. In: Alzheimer's Disease: Lessons from Cell Biology, pp. 70-77, Kosik K. S., Christen V. and Selkoe D. J. (eds), Springer, Berlin
64. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N. et al. (1996) Aβ42(43) is increased in vivo by the PS1/2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2: 864-870
65. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T. et al. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17: 1005-1013
66. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G. et al. (1996) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med. 3: 67-72
67. Duff K., Eckman C., Zehr C., Yu X., Prada C-M., Perez-Tur J. et al. (1996) Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383: 710-713
68. Tomita T., Maruyama K., Saido T. C., Kume H., Shinozaki K., Tokuhiro S. et al. (1997) The presenilin 2 mutation (N1411) linked to familial Alzheimer Disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94: 2025-2030
69. Xia W., Zhang J., Kholodenko D., Citron M., Podlisny M. B., Teplow D. B. et al. (1997) Enhanced production and oligomerization of the 42-residue amyloid beta protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272: 7977-7982(a)
70. Lemere C. A., Lopera F., Kosik K. S., Lendon C. L., Ossa J., Saido T. C. et al. (1996) The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med. 2: 1146-1150
71. Gomez-Isla T., Wasco W., Pettingell W. P., Garubhagavatula S., Schmidt D. D., Jondro P. D. et al. (1997) A novel presenilin 1 gene mutation: increased β-amyloid and neurofibrillary changes. Ann. Neurol. 41: 809-813
72. Mann D. M. A., Iwatsubo T., Cairns N. J., Lantos P. L., Nochlin D., Sumi S. M. et al. (1996) Amyloid β protein (Aβ) deposition in chromosome 14-linked Alzheimer's disease: predominance of Aβ42(43). Ann. Neurol. 40: 149-156
73. Hartmann T., Bieger S. C., Bruhl B., Tienari P. J., Ida N., Allsop D. et al. (1997) Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nature Med. 3: 1016-1020
74. Cook D. G., Forman M. S., Sung J. C., Leight S., Kolson D. L., Iwatsubo T. et al. (1997) Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum intermediate compartment of NT2N cells. Nature Med. 3: 1021-1023
75. Wild-Bode C., Yamazaki T., Capell A., Leimer U., Steiner H., Ihara Y. et al. (1997) Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42. J. Biol. Chem. 272: 16085-16088
76. Citron M., Diehl T. S., Gordon G., Biere A. L., Seubert P. and Selkoe D. J. (1996) Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93: 13170-13175
77. Weidemann A., Paliga K., Dürrwang U., Czech C., Evin G., Masters C. L. et al. (1997) Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein. Nature Med. 3: 328-332
78. Xia W., Zhang J., Koo E. H. and Selkoe D. J. (1997) Interaction between amyloid precursor protein and presenilins in mammalian cells: implication for the pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 94: 8208-8213(b)
79. Levitan D., Doyle T. G., Brousseau D., Lee M. K., Thinakaran G., Slunt H. H. et al. (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 93: 14940-14944
80. Baumeister R., Leimer U., Zweckbronner J., Jakubek C., Gruenberg J. and Haass C. (1997) The Sel-12 mutant phenotype of C. elegans is rescued independent of proteolytic processing by Wt but not mutant presenilin. Genes Funct. 1: 149-159
81. Berezovska O., Xia M., Page K., Wasco W., Tanzi R. and Hyman B. (1997) Developmental Regulation of presenilin mRNA expression parallels Notch expression. J. Neuropathol. Exp. Neurol. 56: 40-44
82. Shen J., Bronson R. T., Chen D. F., Xia W., Selkoe D. J. and Tonegawa S. (1997) Skeletal and CNS defects in presenilin-1-deficient mice. Cell 89: 629-639
83. Artavanis-Tsakonas S., Matsuno K., and Fortini M. E. (1995) Notch signaling. Science 268: 225-232
84. Wong P., Zheng H., Chen H., Becher M. W., Sirinathsinghji D. J. S., Trumbauer M. E. et al. (1997) Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm. Nature 387: 288-292
85. Zhou J., Liyanage U., Medina M., Ho C., Simmons A. D., Lovett M. et al. (1997) Presenilin 1 interacts in brain with a novel member of the Armadillo family. Neuroreport 8: 1489-1494
86. Rawson R. B., Zelenski N. G., Nijhawan D., Ye J., Sakai J., Hasan M. T. et al. (1997) Complementation cloning of S2P. a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell 1: 47-57